Friday, July 27, 2018
Mylan, Fujifilm get nod for Humira biosimilar in Europe
Mylan and Fujifilm Kyowa Kirin Biologics announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use, or CHMP, has adopted a positive opinion for the Marketing Authorization Application of Hulio, the companies’ biosimilar to Humira, or adalimumab, for all indications. The decision of the European Commission on the approval is expected in October.
https://bit.ly/2JYcXp6
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.